Definitive Radiation for High-Risk Spine Metastases (NCT06165419)
A Phase II Study Evaluating Definitive Radiosurgical Decompression in Patients With High-Risk Spinal Metastases
🩺 Plain-English Summary (8th-Grade Level)
This study is looking at whether patients with cancer that has aggressively spread to the spine can be treated with stereotactic body radiation therapy only and avoid a large spine surgery
Who can join: Review the eligibility criteria below.
Location: Stony Brook University Hospital — Stony Brook, New York
Age range: 18 Years
🧪 Interventions in This Study
- SBRT to the spine (RADIATION)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Stony Brook University Hospital — Stony Brook, New York
📞 Contact the Study Coordinator
Phone: (631) 216-2990
Email: hermina.munoz@stonybrookmedicine.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Metastatic Cancer
- A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors — Hartford, Connecticut
- Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers — Chicago, Illinois
- A Study of the ApricityCare Program for Early Detection and Management of Treatment-Related Adverse Events in Patients With Cancer — Houston, Texas
- Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer. — Los Angeles, California
- Biomarkers to Detect Endocrine Therapy Resistance — Madison, Wisconsin
- Niraparib in Tumors Metastatic to the CNS — Boston, Massachusetts
Explore by condition: All Metastatic Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.